0000914190-13-000737.txt : 20131024 0000914190-13-000737.hdr.sgml : 20131024 20131024165217 ACCESSION NUMBER: 0000914190-13-000737 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131022 FILED AS OF DATE: 20131024 DATE AS OF CHANGE: 20131024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardiovascular Systems Inc CENTRAL INDEX KEY: 0001180145 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411698056 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 651 CAMPUS DRIVE CITY: ST. PAUL STATE: MN ZIP: 55112 BUSINESS PHONE: 651-259-1600 MAIL ADDRESS: STREET 1: 651 CAMPUS DRIVE CITY: ST. PAUL STATE: MN ZIP: 55112 FORMER COMPANY: FORMER CONFORMED NAME: REPLIDYNE INC DATE OF NAME CHANGE: 20020813 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Martin David CENTRAL INDEX KEY: 0001304318 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52082 FILM NUMBER: 131168625 MAIL ADDRESS: STREET 1: 651 CAMPUS DRIVE CITY: ST. PAUL STATE: MN ZIP: 55112 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-10-22 0001180145 Cardiovascular Systems Inc CSII 0001304318 Martin David 651 CAMPUS DRIVE ST. PAUL MN 55112 1 1 0 0 President and CEO Common Stock 2013-10-22 4 M 0 50000 8.83 A 404052 D Common Stock 2013-10-22 4 M 0 24717 8.83 A 428769 D Common Stock 2013-10-22 4 S 0 37575 26.271 D 391194 D Common Stock 2013-10-22 4 S 0 37142 27.09 D 354052 D Common Stock 2013-10-23 4 M 0 29363 8.83 A 383415 D Common Stock 2013-10-23 4 S 0 20277 27.29 D 363138 D Common Stock 2013-10-23 4 S 0 9086 28.15 D 354052 D Common Stock 2013-10-23 4 M 0 50000 8.83 A 404052 D Common Stock 2013-10-23 4 S 0 50000 29.3947 D 354052 D Common Stock 1400 I By child Common Stock 1400 I By child Common Stock 1400 I By child Stock Option (right to buy) 8.83 2013-10-22 4 M 0 50000 0 D 2016-07-16 Common Stock 50000 0 D Stock Option (right to buy) 8.83 2013-10-22 4 M 0 24717 0 D 2017-02-14 Common Stock 24717 279363 D Stock Option (right to buy) 8.83 2013-10-23 4 M 0 29363 0 D 2017-02-14 Common Stock 29363 250000 D Stock Option (right to buy) 8.83 2013-10-23 4 M 0 50000 0 D 2017-02-14 Common Stock 50000 200000 D Stock Option (right to buy) 7.90 2017-06-11 Common Stock 90580 90580 D Stock Option (right to buy) 12.15 2017-12-11 Common Stock 234395 234395 D Stock Option (right to buy) 8.75 2019-03-01 Common Stock 32350 32350 D The shares were sold pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.85 to $26.82 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.85 to $27.83 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.99 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.01 to $28.43 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.98 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Fully exercisable. /s/ Alexander Rosenstein as Attorney-in-Fact for David L. Martin pursuant to Power of Attorney previously filed. 2013-10-24